5434132022-04-012022-06-305434132022-04-012022-06-30in-bse-fin:OtherExpenses1Member5434132022-04-012022-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15434132022-04-012022-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25434132022-04-012022-06-30ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares543413TEGANAINE011K01018TEGA INDUSTRIES LIMITEDEquity2022-04-012023-03-312022-08-062022-07-28INRMillionsFirst quarterSingle segmentDesigning, manufacturing and installation of process equipment and accessories2022-08-0619:00:002022-08-0621:00:00Not applicable2022-04-012022-06-30UnauditedConsolidated2444470000-32790000241168000010667900000-5730000038543000049720000913900005877600002123790000287890000028789000096580000-293500006723000002206600000009830000230490000-144990000855000002304900000855000000662930000103.483.46003.483.46Notes to Unaudited Consolidated Financial Results: <BR> <BR> 1.The Unaudited Consolidated Financial Results has been prepared in accordance with the recognition and measurement principles laid down in the applicable Indian Accounting Standards ("Ind AS") as prescribed under section 133 of the Companies Act, 2013, as amended, read with relevant rules thereunder and in terms of regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. This Statement of Unaudited Consolidated Financial Results of the Company have been reviewed by the Audit Committee and approved by the Board of Directors of the Company in their respective meeting held on 6 August 2022. The Unaudited Consolidated Financial Results for the quarter ended 30 June 2022 have been duly reviewed by our Statutory Auditors. <BR> <BR> 2.The Statement includes the results for the quarter ended 31 March 2022, being the balancing figure between audited figures in respect of full financial year ended 31 March 2022 and the published unaudited year to date figures for the nine months period ended 31 December 2021 which were subject to limited review. <BR> <BR> 3.The Group is engaged in the business of designing, manufacturing and installation of process equipments and accessories. The Chief Operating Decision Maker ('CODM') reviews the business as a single segment. Hence no segment disclosure is required. <BR> <BR> 4.The Group and its Joint Venture has assessed the possible impact of COVID-19 on its Unaudited Consolidated Financial Results based on the internal and external information available up to the date of approval of the Unaudited Consolidated Financial Results and concluded no adjustment is required in these Unaudited Consolidated Financial Results. The Group continues to monitor the impact of COVID-19 and the future economic conditions. <BR> <BR> 5.The Parent Company had received foreign direct investment for issue of 668,637 compulsorily convertible participatory preference shares ("CCPP") on 11 May 2011 to Wagner Limited and thereafter issued bonus shares comprising 922,716 equity shares and 8,023,644 CCPP to Wagner Limited on 5 October 2013. As per Para 9(1)(B) of Schedule I to the Foreign Exchange Management (Transfer or issue of security by a person resident outside India) Regulations, 2000 vide Notification no. FEMA 20/2000-RB dated 3 May 2000, amended from time to time, an Indian company is required to file Form FC-GPR to the Regional Office concerned of Reserve Bank of India (“RBI”) with respect to issuance of shares to foreign investor within 30 days from the date of issue. It was observed that there has been an inadvertent delay in filing of Form FC-GPR, which is in contravention of the aforesaid regulation. On 6 August, 2021, the management has made an application to RBI in accordance with Foreign Exchange Management Act, 1999 for compounding of contravention. Subsequent query raised by RBI was duly replied by the Parent Company. Further, the Parent Company has resubmitted the compounding application along with other relevant documents as per the communication from RBI. Based on assessment by the management, the impact of the said contravention is not expected to be material on the financial results. <BR> <BR> During the year ended 31 March 2022 aforesaid 8,692,281 CCPP of Rs. 86.92 million have been converted to 8,692,281 equity shares of Rs. 86.92 million. <BR> <BR> 6.Other income for the quarter ended 30 June 2022 includes net foreign exchange loss of Rs. 57.38 million. <BR> Other Expenses587760000Remeasurement gains/ (loss) on post employment defined benefit plans300000Share of other comprehensive income of joint venture accounted using the equity method3000033000080000Exchange differences on translation of foreign operations-145240000-1452400000